In addition, as for predicting END and poor prognosis following acute ICH, serum MLKL levels at admission presented with analogous AUC as those at other time‐points among those seventy‐three patients, and the results were consistent when compared to NIHSS scores and hematoma volume in all patients. This evidence concerns the gene MLKL and hematoma.